Cell-surface N-linked galactose-containing glycan (N-glycan)

Cell-surface N-linked galactose-containing glycans are complex carbohydrate structures covalently attached to the asparagine residues of proteins, playing a pivotal role in cellular identity and communication (Pinho & Reis, 2015, Nature Reviews Cancer). These glycans often feature terminal galactose residues that serve as essential ligands for galectins, a family of proteins involved in immune regulation, inflammation, and fibrogenesis (Barondes et al., 1994, Cell). In oncology, aberrant expression of these glycans, such as increased branching or altered terminal galactosylation, is associated with tumor metastasis and the modulation of the tumor microenvironment (Varki et al., 2015, Essentials of Glycobiology). Additionally, these structures act as critical receptors for viral entry; for instance, mammalian orthoreoviruses utilize terminal galactose on N-linked glycans to initiate infection of host cells (Frierson et al., 2012, Journal of Virology). Therapeutic strategies targeting these glycans include the development of galectin inhibitors like Belapectin to treat liver fibrosis and cancer, as well as oncolytic viruses like Pelareorep that exploit these glycan receptors for selective tumor targeting (Chauhan et al., 2023, Biomolecules). Understanding the structural distribution of these glycans is vital for developing precise glycan-targeted therapies and diagnostic biomarkers.

Other names

N-linked oligosaccharideGalactose-terminated N-glycanComplex-type N-glycanBeta-galactoside-containing glycanCell-surface glycoconjugate

Serving as a primary attachment receptor for viral entry or acting as a ligand for galectin proteins to modulate immune responses and fibrogenesis.